114 related articles for article (PubMed ID: 35724731)
1. MicroRNA-mediated high expression of PDIA3 was correlated with poor prognosis of patients with LUAD.
Gu X; Li X; Zhang X; Feng R; Zheng M; Liu L; Yang J; Sun H; Zhang Q; Bian T; Zhao H; Liu Y
Genomics; 2022 Jul; 114(4):110417. PubMed ID: 35724731
[TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
3. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
4. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
Chen A; Ding S; Shen X; Lin X
Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
[TBL] [Abstract][Full Text] [Related]
5. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
Front Immunol; 2022; 13():837512. PubMed ID: 35401558
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
7. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
[TBL] [Abstract][Full Text] [Related]
8. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
9. miR-9-5p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting ID4.
Zhu K; Lin J; Chen S; Xu Q
Technol Cancer Res Treat; 2021; 20():15330338211048592. PubMed ID: 34723712
[No Abstract] [Full Text] [Related]
10. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
11. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.
Li W; Pan T; Jiang W; Zhao H
Biomed Pharmacother; 2020 Sep; 129():110217. PubMed ID: 32559619
[TBL] [Abstract][Full Text] [Related]
12. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
[TBL] [Abstract][Full Text] [Related]
13. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
Wang M; Liao Q; Zou P
Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
[TBL] [Abstract][Full Text] [Related]
14. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
Zhang X; Wu Z; Ma K
BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
[TBL] [Abstract][Full Text] [Related]
15. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
18. NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma.
Yan Y; Gao Z; Han H; Zhao Y; Zhang Y; Ma X; Chen H
J Cancer Res Clin Oncol; 2022 Mar; 148(3):565-575. PubMed ID: 34746975
[TBL] [Abstract][Full Text] [Related]
19. Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells.
Han F; Huang D; Huang X; Wang W; Yang S; Chen S
J Cell Mol Med; 2020 Jul; 24(14):7730-7742. PubMed ID: 32476275
[TBL] [Abstract][Full Text] [Related]
20. Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment.
Wu XN; Su D; Mei YD; Xu MQ; Zhang H; Wang ZY; Li LL; Peng L; Jiang JY; Yang JY; Li DJ; Cao H; Xia ZW; Zeng WJ; Cheng Q; Zhang N
Cancer Immunol Immunother; 2021 Oct; 70(10):2835-2850. PubMed ID: 33659999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]